WO2014162487A1 - Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales - Google Patents

Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales Download PDF

Info

Publication number
WO2014162487A1
WO2014162487A1 PCT/JP2013/059998 JP2013059998W WO2014162487A1 WO 2014162487 A1 WO2014162487 A1 WO 2014162487A1 JP 2013059998 W JP2013059998 W JP 2013059998W WO 2014162487 A1 WO2014162487 A1 WO 2014162487A1
Authority
WO
WIPO (PCT)
Prior art keywords
information
drug
patient
medical
information management
Prior art date
Application number
PCT/JP2013/059998
Other languages
English (en)
Japanese (ja)
Inventor
裕也 塔野岡
慎二 加藤
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to PCT/JP2013/059998 priority Critical patent/WO2014162487A1/fr
Publication of WO2014162487A1 publication Critical patent/WO2014162487A1/fr

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Definitions

  • the present invention relates to a medical information management apparatus, a medical information management system, and a control method for the medical information management apparatus that manage medical information such as drug information used in hospitals, for example.
  • drug information such as the administration rate of such drugs is variable information depending on the patient's disease, weight, age, sex, etc.
  • drugs such as “hard limit” and “soft limit” that are not suitable for each patient The information could have an adverse effect on the patient.
  • an object of the present invention is to provide a medical information management apparatus, a medical information management system, and a control method for the medical information management apparatus that can automatically provide drug information suitable for each subject patient or the like.
  • the object is a medical information management device that provides drug information to a medical device, and includes attribute information of a target person who provides the drug, and attribute-specific drug information corresponding to the attribute information.
  • a medical information management device characterized in that it generates drug information for a subject suitable for the subject and provides the medical information for the subject to the medical device.
  • medical agent for example, it has attribute information, such as a patient, For example, information, such as a patient number, age, sex, a weight, and a disease name.
  • attribute information such as a patient
  • information such as a patient number, age, sex, a weight, and a disease name.
  • drug information by attribute corresponding to the attribute information of the patient, for example, flow rate information such as “hard limit” and “soft limit” of the drug for each age, sex, weight, disease name, and the like.
  • the subject drug information suitable for the subject can be specified.
  • the specified subject drug information is provided to the medical device. Therefore, the medical device can automatically acquire the optimal drug information of the target person, and the medical worker who is the operator of the medical device visually recognizes the target part by visually checking the display unit of the medical device. The optimal drug information of the person can be acquired.
  • the attribute of the attribute-specific drug information includes at least age information, sex information, weight information, and disease name information of the subject.
  • the attribute of the attribute-specific drug information includes at least the subject's age information, sex information, weight information, and disease name information, drug information suitable for each subject can be provided.
  • the medical device determines whether the set drug information is within an allowable range of the target drug information.
  • re-input information for prompting re-input is displayed on the display unit of the medical device.
  • the set medicine information is within the allowable range of the target person drug information. It is configured to display. For this reason, the set drug information set in the medical device such as an infusion pump (when the flow rate information of the drug is not appropriate for the patient, the operator is notified of that fact, It is possible to prevent the administration from being performed at the flow rate setting.
  • the medical device such as an infusion pump
  • the object is a method for controlling a medical information management apparatus that provides drug information to a medical device, and includes attribute information of a target person who provides the drug and attribute information corresponding to the attribute information.
  • Control of a medical information management apparatus characterized in that based on the drug information, drug information for a target person suitable for the target person is generated and the drug information for the target person is provided to the medical device. Achieved by the method.
  • medical information management apparatus As described above, according to the present invention, medical information management apparatus, medical information management system, and control method for medical information management apparatus that can automatically provide medicine information suitable for each subject patient or the like. Can be provided.
  • FIG. 3 is a schematic flowchart showing a “drug A flow rate setting step”, which is a main operation example of the “drug library system” shown in FIG. 1;
  • FIG. 5 is another schematic flowchart showing, for example, a “drug A flow rate setting step” which is a main operation example of the “drug library system 1” shown in FIG.
  • FIG. 5 is another schematic flowchart showing, for example, a “drug A flow rate setting step” which is a main operation example of the “drug library system” shown in FIG.
  • FIG. 5 is another schematic flowchart showing, for example, a “drug A flow rate setting step” which is a main operation example of the “drug library system” shown in FIG.
  • FIG. 5 is another schematic flowchart showing, for example, a “drug A flow rate setting step” which is a main operation example of the “drug library system” shown in FIG.
  • FIG. 1 is a schematic diagram showing, for example, “drug library system 1” which is a “medical information management system” of the present invention.
  • the drug library system 1 includes a “medical information management apparatus”, for example, “medicine library server 10”, and “medicine library server 10” is drug information related to a drug, for example, a drug Includes “soft limit” information, which is restriction information on the preferred range of flow rate mL / h at the time of administration of A, etc., and “hard limit” information, which is administration speed restriction information on the absolute administration prohibited range of drug A, etc. It is out.
  • the drug library system 1 includes “medical devices” such as infusion pumps 70a, 70b, and 70c, and these “drug library server 10” and “infusion pump 70a” are connected to be communicable with each other. ing.
  • These infusion pumps 70a and the like are for administering the drug A and the like to the patient. That is, the infusion pump 70a and the like have a configuration in which a tube (not shown) that feeds a drug solution such as the drug A can be disposed therein, and performs operations such as pressing by pressing the tube. Thus, the flow rate of the chemical solution fed in the tube is controlled.
  • the infusion pump 70a and the like have a “display unit” that displays various information, for example, an “infusion pump side display 71”, and an “infusion pump side input device 72” that is an input unit for inputting various information.
  • a “display unit” that displays various information
  • an “infusion pump side display 71” displays various information
  • an “infusion pump side input device 72” that is an input unit for inputting various information.
  • the “infusion pump side input device 72” is a dial, an input button, or the like.
  • the infusion pump transmits “drug library (drug flow rate at the time of administration of the drug A” which is drug information transmitted from the drug library server 10).
  • Information such as “hard limit” and “soft limit” is displayed on the infusion pump-side display 71. Therefore, the medical staff such as a nurse who operates can easily and definitely administer the medicine.
  • the infusion pump 70a and the like and the drug library server 10 shown in FIG. 1 have a computer, and the computer has a CPU (Central Processing Unit), a RAM (Random Access Memory), a ROM (Read Only Memory), and the like (not shown). These are connected via a bus.
  • CPU Central Processing Unit
  • RAM Random Access Memory
  • ROM Read Only Memory
  • FIG. 2 is a schematic block diagram showing the infusion pump 70a and the like shown in FIG.
  • the infusion pump 70 a and the like have an “infusion pump control unit 73”.
  • the infusion pump control unit 73 controls the “infusion pump side input device 72” and the “infusion pump side display 71” shown in FIG. 1, and communicates with the “medicine library server 10” in FIG.
  • the pump side communication device 74 "is controlled.
  • the “infusion pump control unit 73” also controls various storage units shown in FIG. 2, which will be described later.
  • FIG. 3 is a schematic block diagram showing the drug library server 10 shown in FIG.
  • the drug library server 10 includes a “server control unit 11”.
  • the “server control unit 11” includes a “server-side input device 12” that inputs various information, a “server-side display 13” that displays various information, and the “server-side communication device 14” that communicates with the infusion pump 70a of FIG.
  • the “first server various storage units 20”, “second server various storage units 30”, and “third server various storage units 40” shown in FIG. 4 to 6 are schematic blocks showing contents of “first server various information storage unit 20”, “second server various information storage unit 30”, and “third server various information storage unit 40” in FIG. 3, respectively. FIG. These contents will be described later.
  • FIGS. 7 to 11 are schematic flowcharts showing, for example, “drug A flow rate setting step” which is a main operation example of the “drug library system 1” shown in FIG.
  • drug A flow rate setting step which is a main operation example of the “drug library system 1” shown in FIG.
  • the operation and the like will be described according to the flowcharts of FIGS. 7 to 11, and the configuration and the like of FIGS. 1 to 6 will be described.
  • step ST for example, a nurse who is a user who is installed on the bedside of a patient in a hospital or the like and wants to administer the medicine A to the patient at a predetermined flow rate using the infusion pump 70a of FIG.
  • the patient identification number for example, patient number “1001”
  • the infusion pump 70 a via the infusion pump-side input device 72 or the like.
  • the infusion pump 70a transmits the patient identification number (1001) acquired in ST1 to the drug library server 10 of FIG. Specifically, it is transmitted via the infusion pump side communication device 74 of FIG.
  • the drug library server 10 stores the received “patient identification number (1001)” in the “individual patient identification number storage unit 21” in FIG.
  • the drug library server 10 refers to the “patient information storage unit 22” in FIG. 4 and corresponds to “patient identification information (1001)” stored in the “individual patient identification number storage unit 21” in FIG. It is determined whether or not “age information” is present in “patient information 22a”.
  • This “patient information 22a” is an example of “attribute information”.
  • “age information” is included in “patient information 22a” in ST4, the process proceeds to ST5.
  • “personal drug information generation reference information 23a” which is “attribute-specific drug information” in the “personal drug information generation reference information storage unit 23” in FIG. 4 is referred to.
  • the “personal medicine information generation reference information 23a” is, for example, “hard limit” or “soft limit” flow rate information of the medicine A. These “hard limit” and “soft limit” information are more optimal numerical values based on parameters such as age information, sex information, weight information, and disease name information.
  • “patient-specific drug information (hard limit, soft limit, etc.)” is generated based on the “age information” of the “personal drug information generation reference information 23a”, and “patient-specific drug information storage” of FIG. Part 32 ".
  • ST7 it is determined whether or not there is “sex information” in “patient information 22a” corresponding to “patient identification information (1001)” in “individual patient identification number storage unit 21” in FIG. This determination is made by the “provisional patient-specific drug information generation unit (program) 33” in FIG.
  • “provisional patient-specific drug information (hard limit, soft limit, etc.)” is generated based on “age information” and “sex information” of “personal drug information generation reference information 23a” in FIG.
  • the information is stored in the provisional patient-specific drug information storage unit 34 ”.
  • “patient information 22a” in FIG. 4 corresponding to “patient identification information“ 1001 ” has“ sex information “female”, and based on this, “personal drug information generation reference information 23a” in FIG.
  • data “hard limit 10 to 150 mL / h” and “soft limit 20 to 80 mL / h” are applicable.
  • this data is stored in the “provisional patient-specific drug information storage unit 34”. Specifically, it is stored as “(a) hard limit 10 to 150 mL / h, soft limit 20 to 80 mL / h” in FIG. Specifically, these operations are executed by the “provisional patient-specific drug information generation unit (program) 33” in FIG.
  • the “drug information range determination unit (program) 35” in FIG. 5 operates, and refers to the “patient-specific drug information storage unit 32” and the “provisional patient-specific drug information storage unit 34” in FIG.
  • the “hard limit” and “soft limit” data of the “patient-specific drug information” determines whether the range is stricter than the “hard limit” and “soft limit” data of the “patient-specific drug information”.
  • “(a) hard limit 10 to 150 mL / h, soft limit 20 to 80 mL / h” of “provisional patient-specific drug information storage unit 34” in FIG. 5 is “patient-specific drug information storage unit 32”.
  • “(1) Hard limit 10 to 200 mL / h, soft limit 20 to 100 mL / h) the range is stricter, so“ YES ”and the process proceeds to ST10.
  • “provisional patient-specific drug information” is updated and registered as “patient-specific drug information”.
  • “(a) hard limit 10 to 150 mL / h, soft limit 20 to 80 mL / h” in “provisional patient-specific drug information storage unit 34” in FIG. "(2) Hard limit 10 to 150 mL / h, Soft limit 20 to 80 mL / h” of the section 32 "is the update information (2) of (1).
  • This operation is also executed by the “drug information range determination unit (program) 35” of FIG.
  • the data of “(2)” in “patient-specific drug information” becomes drug information (information such as hard limit and soft limit) suitable for the “age” and “sex” information of the patient.
  • ST11 it is determined whether or not there is “weight information” in “patient information 22a” corresponding to “patient identification information (1001)” in “individual patient identification number storage unit 21” in FIG. This determination is made by the “provisional patient-specific drug information generation unit (program) 33” in FIG.
  • “patient information 22a” in FIG. 4 corresponding to “patient identification information“ 1001 ” has“ weight information “40 kg” ”, which is equal to or less than the reference weight.
  • “medical drug information generation reference information 23a” the data “hard limit 10 to 100 mL / h,“ soft limit 20 to 60 mL / h ”are applicable. For this reason, this data is overwritten and stored in the “provisional patient-specific drug information storage unit 34”.
  • “(b)“ hard limit 10 to 100 mL / h ”and“ soft limit 20 to 60 mL / h ” are overwritten and stored in place of the data“ (a) ”in FIG.
  • these operations are executed by the “provisional patient-specific drug information generation unit (program) 33” in FIG.
  • the “drug information range determination unit (program) 35” in FIG. 5 operates, and refers to the “patient-specific drug information storage unit 32” and the “provisional patient-specific drug information storage unit 34” in FIG.
  • the "hard limit” and “soft limit” data of "Patient Information by Patient” determines whether the range is stricter than "Hard Limit” and “Soft Limit” data, which are parameters of "Patient Information by Patient” .
  • “(b) hard limit 10 to 100 mL / h, soft limit 20 to 60 mL / h” of “provisional patient-specific drug information storage unit 34” in FIG. 5 is “patient-specific drug information storage unit 32”.
  • “provisional patient-specific drug information” is updated and registered as “patient-specific drug information”.
  • “(b) hard limit 10 to 100 mL / h, soft limit 20 to 60 mL / h” in “provisional patient-specific drug information storage unit 34” in FIG. "(3) Hard limit 10 to 100 mL / h, soft limit 20 to 60 mL / h” of section 32 "is the update information (3) of 2).
  • This operation is also executed by the “drug information range determination unit (program) 35” of FIG.
  • the “(3)” data of “Patient Information by Patient” is drug information suitable for the “age”, “gender” and “weight” information of the patient (information such as hard limit and soft limit). It becomes.
  • ST15 it is determined whether or not “patient information 22a” corresponding to “patient identification information (1001)” in “individual patient identification number storage unit 21” in FIG. 4 includes “disease name information”. This determination is made by the “provisional patient-specific drug information generation unit (program) 33” in FIG.
  • “patient information 22a” includes “disease name information”
  • the process proceeds to ST16.
  • ST16 based on “age information”, “sex information”, “weight information”, and “disease name information” of “personal drug information generation reference information 23a” in FIG. Limit etc.) ”is generated and overwritten and stored in the“ provisional patient-specific drug information storage unit 34 ”in FIG.
  • “patient information 22a” in FIG. 4 corresponding to “patient identification information“ 1001 ” has“ disease name information “renal failure”, and based on this, “personal drug information generation criteria in FIG.
  • the data “hard limit 10 to 50 mL / h,“ soft limit 20 to 50 mL / h ” are applicable. For this reason, this data is overwritten and stored in the “provisional patient-specific drug information storage unit”. Specifically, “(c)“ hard limit 10 to 50 mL / h ”and“ soft limit 20 to 50 mL / h ”are overwritten and stored in place of the data“ (b) ”in FIG. Specifically, these operations are executed by the “provisional patient-specific drug information generation unit (program) 33” in FIG.
  • the process proceeds to ST17.
  • the “final patient-specific drug information generation unit (program) 41” in FIG. 6 operates, and refers to the “patient-specific drug information storage unit 32” and the “provisional patient-specific drug information storage unit 34” in FIG.
  • the “hard limit” and “soft limit” data of “provisional patient-specific drug information” determines whether the range is stricter than the “hard limit” and “soft limit” data of “patient-specific drug information”.
  • “(c) hard limit 10 to 50 mL / h, soft limit 20 to 50 mL / h” of “provisional patient-specific drug information storage unit 34” in FIG. 5 is “patient-specific drug information storage unit 32”.
  • “(3) Hard limit 10 to 100 mL / h, soft limit 20 to 60 mL / h) the range is stricter, so“ YES ”and the process proceeds to ST18.
  • “provisional patient-specific drug information” in FIG. 5 is registered as “final patient-specific drug information” in “final patient-specific drug information storage unit 41” in FIG.
  • This “final patient-specific drug information” is an example of “subject drug information”.
  • This “final patient-specific drug information” is drug information such as “hard limit” and “soft limit” that are optimal when the drug A is administered to the patient. That is, this “final patient-specific drug information” is drug information such as the optimal “hard limit” and “soft limit” in consideration of the age, sex, weight, and disease name of the patient.
  • “patient-specific drug information” in FIG. 5 is registered as “final patient-specific drug information” in “final patient-specific drug information storage unit 41” in FIG.
  • ST20 it is determined whether or not the infusion pump 70a has been set for the flow rate of the medicine A by a nurse or the like. If it is determined in ST20 that the flow rate of medicine A has been set, the process proceeds to ST21.
  • ST21 the flow rate setting information of “drug A” input by the nurse or the like from the “infusion pump side input device 72” is stored in the “drug flow rate setting information storage unit 75” of FIG. Remember as.
  • the “drug flow rate setting information determination unit (program) 76” in FIG. 2 operates to acquire “final patient-specific drug information” in the “final patient-specific drug information storage unit 42” in FIG. Refer to “Hard limit information”. In the present embodiment, for example, “10 to 50 mL / h”.
  • the “drug flow rate setting information determining unit (program) 76” in FIG. 2 operates, and the “drug flow rate setting information” in FIG. 2 is set to allow the “hard limit information (10 to 50 mL / h)”. Determine if it is within range.
  • the process proceeds to ST24.
  • the infusion pump 70a or the like displays a “setting confirmation (re-input)” screen on the “infusion pump-side display 71” and prompts the nurse or the like to re-input the flow rate setting. Therefore, in the present embodiment, not only the optimal drug flow rate information of the patient can be acquired, but also whether the actually input flow rate information is appropriate based on the optimal drug flow rate information. Judgment can be made and notified to nurses and the like.
  • the “drug flow rate setting information” in FIG. 2 is within the allowable range of the “hard limit information (10 to 50 mL / h)” in ST23, the process proceeds to ST26.
  • the “drug flow rate setting information determination unit (program) 76” in FIG. 2 operates to acquire “final patient-specific drug information” in the “final patient-specific drug information storage unit 42” in FIG. Refer to “Soft limit information”. In the present embodiment, for example, “20 to 50 mL / h”.
  • it is determined whether or not “drug flow rate setting information” in FIG. 2 is within the allowable range of this “soft limit information (20 to 50 mL / h)”.
  • the flow rate information is reissued to the nurse or the like in ST24 and ST25 described above. You will be prompted for input.
  • the present invention is not limited to the above-described embodiment.
  • the infusion pump 70a and the like have been described as an example of the medical device, but the present invention is not limited to this, and can be suitably applied to other medical devices such as a syringe pump.
  • the infusion pump 70a and the like are configured to determine whether or not the “hard limit information” or the like input to the infusion pump 70a or the like by a nurse or the like in ST23 or the like.
  • the medicine library server 10 may be configured to perform determination.
  • Drug information range determination unit (program), 40 ... Third various information storage unit , 41 ... Drugs for each patient Information generating unit (program), 42... Last patient-specific drug information storage unit, 70 a, 70 b, 70 c, infusion pump, 71, infusion pump side display, 72, infusion pump side input device, 73 ... infusion pump control unit, 74 ... infusion pump side communication device, 75 ... drug flow rate setting information storage unit, 76 ... drug flow rate setting information judgment unit (program)

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Le problème décrit par la présente invention est de pourvoir à un dispositif de gestion d'informations médicales ou autre pouvant fournir automatiquement des informations de médicament appropriées à chaque patient ou autre sujet. La solution selon l'invention porte sur un dispositif de gestion d'informations médicales (10) conçu de sorte à fournir des informations de médicament à un dispositif médical (70a), et conçu de sorte à fournir des informations de médicament pour le sujet à un dispositif médical par génération d'informations de médicament (42) pour le sujet qui sont appropriées pour ledit sujet, sur la base d'informations d'attribut de sujet (22a) en vue de dispenser ledit médicament, et des informations de médicament spécifiques (23a) à un attribut correspondant auxdites informations d'attribut.
PCT/JP2013/059998 2013-04-01 2013-04-01 Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales WO2014162487A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/059998 WO2014162487A1 (fr) 2013-04-01 2013-04-01 Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/059998 WO2014162487A1 (fr) 2013-04-01 2013-04-01 Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales

Publications (1)

Publication Number Publication Date
WO2014162487A1 true WO2014162487A1 (fr) 2014-10-09

Family

ID=51657820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/059998 WO2014162487A1 (fr) 2013-04-01 2013-04-01 Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales

Country Status (1)

Country Link
WO (1) WO2014162487A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004267514A (ja) * 2003-03-10 2004-09-30 Nippon Telegraph & Telephone East Corp 用量決定支援装置、方法およびプログラム
JP2005100224A (ja) * 2003-09-26 2005-04-14 Tosho Inc 抗ガン剤適正使用支援システム
JP2005196587A (ja) * 2004-01-08 2005-07-21 Matsushita Electric Ind Co Ltd 医薬品投与量演算装置

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004267514A (ja) * 2003-03-10 2004-09-30 Nippon Telegraph & Telephone East Corp 用量決定支援装置、方法およびプログラム
JP2005100224A (ja) * 2003-09-26 2005-04-14 Tosho Inc 抗ガン剤適正使用支援システム
JP2005196587A (ja) * 2004-01-08 2005-07-21 Matsushita Electric Ind Co Ltd 医薬品投与量演算装置

Similar Documents

Publication Publication Date Title
US11868161B2 (en) Synchronized display of screen content on networked devices
US11574721B2 (en) Matching delayed infusion auto-programs with manually entered infusion programs
JP6632551B2 (ja) 注入ポンプのエラー表示
US11278671B2 (en) Infusion pump with safety sequence keypad
US20070233050A1 (en) Medication administration and management system and method
WO2014049659A1 (fr) Dispositif de montage d'équipement et procédé de contrôle pour le dispositif de montage d'équipement
US20140330241A1 (en) Infusion system with rapid access to code medication information
JP2019048232A (ja) 患者治療装置固有構成出力
EP2759979B1 (fr) Dispositif de gestion d'informations sur des médicaments et procédé de gestion d'informations sur des médicaments
US20230112979A1 (en) Infusion pump with alarm manager
CN113730715B (zh) 一种遥控麻醉辅助控制方法、装置、电子设备及存储介质
WO2014162487A1 (fr) Dispositif de gestion d'informations médicales, système de gestion d'informations médicales et procédé de commande de dispositif de gestion d'informations médicales
JPWO2016157655A1 (ja) 送液ポンプ管理システム
Kumar et al. Hybrid approach for automatic drug dispensing and control
Bain The Cellnovo insulin delivery system
WO2014162485A1 (fr) Système et procédé de gestion d'informations médicales
JP6068619B2 (ja) 医療情報管理装置、医療情報管理システム及び医療情報管理装置の制御方法
US20220088305A1 (en) Infusion pump with patient weight check
WO2014162486A1 (fr) Dispositif et procédé de gestion d'informations médicales
JP6068620B2 (ja) 医療情報管理装置、医療情報管理システム及び医療情報管理装置の制御方法
WO2013128886A1 (fr) Pompe d'administration de liquide, et système de réseau
WO2014118887A1 (fr) Dispositif de gestion d'informations médicales, système de gestion d'informations médicales, et procédé de commande pour le dispositif de gestion d'informations médicales

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13881284

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13881284

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP